Observational Study About In-patients Admitted With Fever
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Jun 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients who are hospitalized with a fever, which is a common symptom often linked to infections. The goal is to learn more about the causes of fever, the characteristics of these patients, and how well they do after receiving treatment. Researchers want to find out if there are specific indicators (like blood tests) that can help predict whether someone has an infectious or non-infectious fever and how their condition might progress.
To participate in this study, you need to be a patient admitted to the infectious diseases department because of a fever. The study is open to patients of all ages and genders, but you must agree to participate and sign a consent form. If you join, you can expect to provide information about your health and treatment, which will help doctors better understand fever and improve future care for patients. This study is currently recruiting participants, so there’s an opportunity to be part of important research that could benefit many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients admitted to department of infectious diseases because of fever
- Exclusion Criteria:
- • patents who refuse to sign informed consent
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Trial Officials
Yan Huang
Principal Investigator
Xiangya Hospital of Central South University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials